Veracyte Inc. reported strong Q4 earnings, with significant improvement in revenue and profitability

From Nasdaq.: 2025-02-24 17:30:28

Veracyte Inc. reported earnings of $5.11 million in Q4, a significant improvement from the -$28.29 million in the same period last year. EPS also increased to $0.06 from -$0.39. Adjusted earnings were $28.95 million or $0.36 per share. Revenue for Q4 was $118.63 million, up from $98.20 million in the same period last year. These strong financial results show a positive trend for Veracyte Inc. as they continue to grow and increase their profitability.



Read more at Nasdaq.: Veracyte Inc. Q4 Earnings Summary